New 2025 guidelines from the American Diabetes Association emphasize the importance of early detection, highlighting that first-degree relatives of individuals with Type 1 Diabetes (T1D)… Read More »Type 1 diabetes can be fast, but we can be faster: A call to boost early detection
It was a pleasure for DiaUnion to participate in the conference on Future Screening organized by Leading Health Care Foundation / ASSET. The day offered… Read More »DiaUnion participated in Stockholm conference on Future Screening
On World Diabetes Day we in DiaUnion stand in solidarity to bring attention to the challenges of living with type 1 diabetes (T1D) for individuals… Read More »DiaUnion marks World Diabetes Day 2024
At IDS2024 today, Samia Hamdan presented how DiaUnion now uses ADAP (Antibody Detection by Agglutination-PCR) multiplex assays as the first line of screening. This means… Read More »DiaUnion’s Samia Hamdan presented at the Immunology of Diabetes Society annual congres
CONCLUSIONThe study confirms the high prevalence of associated autoimmunity in first-degree relatives, which supports the relevance of screening for multiple autoimmune diseases in this population.… Read More »The DiaUnion project featured in the European Medical Journal:
Scaringly, there is a growing incidence of Type 1 Diabetes – of particular concern is the sharp increase in T1D among children. T1D has developed… Read More »Fighting Type 1 Diabetes across borders!
DiaUnion’s Samia Hamdan presented her poster “Screening for autoimmune thyroid disease, celiac disease and type 1 diabetes using multiplex ADAP assays: TRIAD2023 study” today at… Read More »DiaUnion’s Samia Hamdan presented her poster at the EASD conference
“Screening and monitoring for presymptomatic type 1 diabetes: The DiaUnion project” Thanks Julie Hviid Klæbel for a great presentation at the European Association for the… Read More »DiaUnion postdoc Julie Hviid Klæbel presented at the EASD conference
19(!) type 1 diabetes disease-modifying pipeline drugs presented at the INNODIA symposium at European Association for the Study of Diabetes e.V. (EASD) in Madrid this… Read More »19 type 1 diabetes disease-modifying pipeline drugs presented at the EASD INNODIA symposium
Watch the news feature where Sophie Hindkjær, who lives with type 1 diabetes, explains why she will have her children screened in DiaUnion’s type 1… Read More »Sophie Hindkjær, who lives with type 1 diabetes, explains why she will have her children screened
